Christopher M. Duke
Chief Executive Officer at Gennao Bio, Inc.
Network origin in Christopher M. Duke first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Extinct | Pharmaceuticals: Major | 13 | |
Gennao Bio, Inc.
 Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Gennao Bio, Inc. is a privately-held genetic medicines company that is developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing its proprietary gene monoclonal antibody (gmab) platform technology. The company is based in Pennington, NJ. The company's gmab technology uses a novel, cell-penetrating antibody to non-covalently bind to, and deliver therapeutic levels of a wide variety of nucleic acid payloads, to select cells. Gennao Bio is initially focusing on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases. The company's non-viral delivery platform offers significant advantages over traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and dose optimization, and can be easily and affordably manufactured. The company was founded in 2020 by Bruce Turner, Elias Quijano, Peter M. Glazer, Stephen P. Squinto. Christopher M. Duke has been the CEO of the company since 2021.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Christopher M. Duke via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | General Counsel General Counsel Corporate Officer/Principal | |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | College/University | Masters Business Admin | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| EXELON CORPORATION | Electric Utilities | Director/Board Member | |
| ONCOLYTICS BIOTECH INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| SONOMA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| TENGION, INC. | Biotechnology | Director of Finance/CFO | |
| CELANESE CORPORATION | Chemicals: Specialty | Corporate Officer/Principal | |
| ONCOSEC MEDICAL INCORPORATED | Medical/Nursing Services | Chief Executive Officer Director/Board Member Director of Finance/CFO General Counsel | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree | |
| Boston University | College/University | Undergraduate Degree Undergraduate Degree | |
PharmaNet, Inc.
 PharmaNet, Inc. Medical DistributorsDistribution Services PharmaNet, Inc. researches and develops new drugs and provides clinical development & consulting services. Its services include strategic planning, data management, bio-statistics, site management, study monitoring, protocol/CRF design, project management, information technology, quality control and assurance and regulatory affairs. The company was founded in 1996 by Jeffrey P. McMullen and is headquartered in Princeton, NJ. | Medical Distributors | General Counsel | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
| Universidad Nacional Autónoma de México | College/University | Doctorate Degree | |
| SCHRÖDINGER, INC. | Packaged Software | Director/Board Member | |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director of Finance/CFO | |
| United States Marine Corps | Sovereign | Corporate Officer/Principal | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor | |
Bracco Diagnostics, Inc.
 Bracco Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Bracco Diagnostics, Inc. manufactures chemicals and allied products. It develops and markets diagnostic pharmaceutical products including Isovue X-ray contrast agent, ProHance MRI contrast agent and nuclear medicine products pharmaceuticals in North America. It is a subsidiary of Bracco SPA. The company is headquartered in Princeton, NJ | Pharmaceuticals: Major | General Counsel | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| IBIO, INC. | Pharmaceuticals: Other | Director/Board Member | |
| IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
| Dickinson Law School | College/University | Graduate Degree Graduate Degree | |
| UROGEN PHARMA LTD. | Biotechnology | Director of Finance/CFO | |
Instituto Nacional de Ciencias Medicas y Nutricion
 Instituto Nacional de Ciencias Medicas y Nutricion Hospital/Nursing ManagementHealth Services Instituto Nacional de Ciencias Medicas y Nutricion operates hospitals. The private company is based in Mexico City, Mexico. | Hospital/Nursing Management | Corporate Officer/Principal | |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Pharmaceuticals: Major | Director/Board Member | |
| NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Director of Finance/CFO | |
Elucida Oncology, Inc.
 Elucida Oncology, Inc. BiotechnologyHealth Technology Elucida Oncology, Inc. operates as a biotechnology company which focuses on clinical research and development. The company was founded by Isaac Blech, Michelle Bradbury, Ulrich Weisner, and Steven Larson in 2014 and is headquartered in Monmouth Junction, NJ. | Biotechnology | Director/Board Member | |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Harmony Biosciences LLC
 Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Harmony Biosciences LLC operates as a biopharmaceutical company which develops therapies to help patients with unmet medical needs. It provides novel treatment options to patients with orphan and rare conditions, with an emphasis on central nervous system disorders. The company is headquartered in Plymouth Meeting, PA. | Pharmaceuticals: Major | Director/Board Member | |
Antios Therapeutics, Inc.
 Antios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Antios Therapeutics, Inc. operates as a biopharmaceutical company devoted to developing therapies for viral diseases. The company was founded by Abel De La Rosa, Doug Mayers and Idean Marvasty on October 30, 2018 and is headquartered in Atlanta, GA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| SEELOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| ADVAXIS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
| SPRINGWORKS THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
| PHATHOM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Merck & Co. | Real Estate Development | Investor Relations Contact | |
| Wuju Foods LLC | Chairman | ||
| Larkspur Health LLC | Founder | ||
Terremoto Biosciences, Inc.
 Terremoto Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Terremoto Biosciences, Inc. is a drug discovery and development company that creates highly targeted, small molecule medicines with unmatched selectivity, potency, and efficacy to deliver superior therapeutic benefit to patients. The company is based in San Francisco, CA. Terremoto is supported by leading investors, including OrbiMed, Third Rock Ventures, EcoR1 Capital, Novo Holdings, and Cormorant Capital. The company aims to expand the universe of drug targets and improve existing medicines by unleashing the power of covalent chemistry. Terremoto was founded by Peter A. Thompson and Matthew P. Jacobson, and Peter A. Thompson has been the CEO since incorporation. | Pharmaceuticals: Major | Founder | |
| ARS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Usmc Officer Candidates School | College/University | Undergraduate Degree | |
| AYALA PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
| SYNERGY PHARMACEUTICALS INC | Pharmaceuticals: Major | Director of Finance/CFO | |
Sellas Life Sciences Group Ltd.
 Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Sellas Life Sciences Group Ltd. manufactures pharmaceutical products. It focuses on innovative products to treat cancer and central nervous system diseases. The firm’s product candidate, licensed from Memorial Sloan-Kettering Cancer Center is a late-stage innovative WT1-targeting synthetic heteroclitic epitope immunotherapeutic in development for hematological malignancies and solid tumors characterized by an overexpression of the WT1 (Wilms Tumor Protein) antigen. The company was founded by Angelos M. Stergiou in 2012 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistics
International
| United States | 40 |
| Israel | 3 |
| Mexico | 3 |
| United Kingdom | 2 |
| Canada | 2 |
Sectoral
| Health Technology | 30 |
| Consumer Services | 7 |
| Commercial Services | 4 |
| Finance | 4 |
| Health Services | 3 |
Operational
| Director/Board Member | 137 |
| Corporate Officer/Principal | 46 |
| Independent Dir/Board Member | 44 |
| Chief Executive Officer | 29 |
| President | 26 |
Most connected contacts
| Insiders | |
|---|---|
| Thomas Ridge | 49 |
| Stephen P. Squinto | 40 |
| Peter Thompson | 39 |
| Daniel O'Connor | 22 |
| Gregory Mayes | 18 |
| Julie Hambleton | 15 |
| Gary Sender | 14 |
| Andres Gutiérrez | 13 |
| Bradley Campbell | 13 |
| Ken Berlin | 11 |
| Mayo Pujols | 11 |
| Molly Henderson | 10 |
| Sara Bonstein | 9 |
| Bruce Turner | 9 |
| Craig David Gordon | 8 |
- Stock Market
- Insiders
- Christopher M. Duke
- Company connections